CRISPR and Genome Editing – News and Features
News
genOway Signs a $2 Million Contract with a US-based Biopharmaceutical Firm
Under the agreement, genOway will provide its client with customized genetically modified mouse lines tailored to the researchers’ needs.
News
Institute for Systems Biology Completes Purchase of Cyntellect LEAP™ System
ISB plans to exploit LEAP's in situ live cell manipulation capabilities to enable new approaches to functionally cloning immune cells.
News
Inovio Biomedical Redirects Strategic Emphasis Toward DNA Vaccines and DNA Delivery
Company expanding R&D to advance its DNA delivery technology and develop proprietary DNA vaccines for cancer and chronic infectious diseases.
News
Stem Cell Team Wins 2007 Nobel for Medicine
Stem cell researchers Mario Capecchi, Martin Evans and Oliver Smithies won the 2007 Nobel prize for medicine or physiology for their work on gene changes in mice using embryonic cells.
News
Amaxa-Promega Partnership to Enable Simplified Monitoring of Cell Signaling Events in Stem Cells, Cancer Cells and Primary Cells
Both companies will develop applications that will provide cell biologists broader access to monitor cell signaling events in difficult-to-transfect cells.
News
Caliper LS Awarded National Institute of Environmental Health Services Contract Valued to $7 Million
Caliper Discovery Alliances & Services to develop customized transgenic and knock-out mouse models.
News
Stem Cells Show Promise for Treating Huntington's Disease
The song of the canary aids the quest to create medium spiny neurons.
News
New Mechanism Discovered for DNA Recombination and Repair
A biochemistry research team at the Institute of Biological Chemistry, Academia Sinica, has discovered that the RecA family recombinases function as a new type of rotary motor proteins to repair DNA damages.
News
GATC Biotech Announces Collaboration Agreement to Develop Comprehensive DNA-Based Sepsis Diagnostic
the collaboration, which aims to develop a comprehensive DNA microarray-based diagnostic test able to detect both bacterial and fungal sepsis-triggering pathogens.
News
Polyplus-transfection to Supply RNAi Therapeutic Delivery Technology to Alnylam Pharmaceuticals
Collaboration targets improving delivery of RNAi-based therapies
Advertisement